PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 77 filers reported holding PHATHOM PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.36 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $61,272,000 | -38.7% | 3,115,008 | 0.0% | 1.08% | -22.1% |
| Q3 2021 | $99,992,000 | -5.2% | 3,115,008 | 0.0% | 1.39% | -18.1% |
| Q2 2021 | $105,443,000 | -9.9% | 3,115,008 | 0.0% | 1.69% | -4.1% |
| Q1 2021 | $117,000,000 | -7.9% | 3,115,008 | -18.6% | 1.76% | -0.7% |
| Q4 2020 | $127,067,000 | -9.4% | 3,825,008 | 0.0% | 1.78% | -30.8% |
| Q3 2020 | $140,263,000 | +11.4% | 3,825,008 | 0.0% | 2.57% | +4.6% |
| Q2 2020 | $125,881,000 | +31.5% | 3,825,008 | +3.2% | 2.45% | -18.9% |
| Q1 2020 | $95,725,000 | -15.7% | 3,707,408 | +1.7% | 3.02% | -12.2% |
| Q4 2019 | $113,562,000 | – | 3,646,808 | – | 3.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |